ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681642 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681642; 2) Community: the network communities that were significantly associated with the response to NSC 681642; 3) Molecule: the relationships between components within communities and NSC 681642; 4) MDR: the compounds that were significantly associated with the NSC 681642.

NSC Compound Enrichment Correlation
NSC 659687 6H-Pyrido[4,3-b]carbazole-1-carboxamide, 9-hydroxy- 5,6-dimethyl-N-[2-(dimethylamino)ethyl]-, dihydrochloride 0.000100665759440623 0.68388574
NSC 48229 Null 0.000115730130665035 -0.20379766
NSC 683555 Camptothecin Derivative 0.000115730130665038 0.86830861
NSC 626167 Aplidazole C . TFA 0.000143065913599158 0.18788168
NSC 681646 Camptothecin Derivative 0.000155853121040032 0.97370657
NSC 740476 Null 0.000155853121040032 0.41891402
NSC 648365 Insulin-Methotrexate conjugate 0.000294004970380715 0.60415722
NSC 653255 1-Cyano-2-(3',4',5'-trimethoxybenzyl)-10-N-methylphenothiazine 0.000305106126354731 0.33777369
NSC 684409 18-Norestr-4-en-3-one, 17-ethynyl-13-ethyl- 17.beta.-hydroxy-,2-[(9,10-dihydro-10-oxo-4-acridinyl)carbonyl]hydrazone 0.000305106126354733 0.34237034
NSC 76455 Antibiotic from Streptomyces luteogriseus 0.000305106126354733 0.068865456
Total:75  Current:1    [First] [Prev] [Next] [Last]